Clinical Trials Logo

Mixed Sleep Apnea clinical trials

View clinical trials related to Mixed Sleep Apnea.

Filter by:
  • None
  • Page 1

NCT ID: NCT03421704 Completed - Central Sleep Apnea Clinical Trials

A Prospective Multicenter Registry of Patients With Sleep Disordered Breathing Treated With DreamStation BiPAP autoSV.

autoSVREGDE
Start date: January 25, 2018
Phase:
Study type: Observational [Patient Registry]

This multi-center observational study will prospectively collect data from patients who have an indication for servo ventilation therapy. This registry is intended to characterize the patient populations that may benefit from DreamStation BiPAP autoSV therapy (PR DS-autoSV, Philips Respironics, Monroeville, PA) in real life settings. In addition, this registry will assess adherence to the PR DS-autoSV therapy, the therapeutic benefits, collect morbidity and mortality data of servo ventilation in patients with central sleep apnea (CSA) and complex sleep-disordered breathing (SDB).

NCT ID: NCT03043716 Active, not recruiting - Clinical trials for Obstructive Sleep Apnea

Long-term Observation of PAP-therapy With Telemonitoring: Telemedicine Registry TelePAP

TelePAP
Start date: August 1, 2017
Phase:
Study type: Observational [Patient Registry]

Telemonitoring for Positive Airway Pressure (PAP) therapy might help to establish and maintain long-term therapy adherence and thus support the beneficial effects of PAP therapy on long-term outcomes.

NCT ID: NCT03032029 Completed - Clinical trials for Obstructive Sleep Apnea

Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation

READ-ASV
Start date: September 5, 2017
Phase:
Study type: Observational [Patient Registry]

Phase 1: The European ASV Registry (short name) will investigate the use of Adaptive Servo-Ventilation in non-heart failure conditions. The purpose is to examine the effects of ASV on quality of life, daytime symptoms and sleep, to describe usage patterns of ASV with regards to patient characteristics and to document adverse events related to therapy for a therapy safety analysis. A pilot phase will enrol at least 200 patients to test the feasibility of the registry. After the pilot phase will be completed and an intermediate data analysis had been performed, the registry will be expanded over several countries across Europe with the goal of enrolling up to 800 patients over a period of 5 years. Phase 2: The READ-ASV Registry (short name) will investigate the use of Adaptive Servo-Ventilation in non-heart failure conditions. The purpose is to examine the effects of ASV on quality of life, daytime symptoms and sleep, to describe usage patterns of ASV with regards to patient characteristics and to document adverse events related to therapy for a therapy safety analysis.

NCT ID: NCT02034175 Completed - Clinical trials for Obstructive Sleep Apnea

Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing

Start date: February 1, 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the accuracy of Somnarus diagnostic technology for diagnosis of sleep apnea in human subjects. This includes evaluation of Somnarus technology in Obstructive Sleep Apnea (OSA) and Central Sleep Apnea (CSA), including Cheyne - Stokes respiration (CSR).